Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. - Wikidata - awgldk - TriplyDB

Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up.

Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up.

http://www.wikidata.org/entity/Q35408379

about

Immune therapy in type 1 diabetes mellitus Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study Type 1 diabetes mellitus.Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease.Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up.Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youth.Islet Autoantibody Measurements from Dried Blood Spots on Filter Paper Strongly Correlate to Serum Levels.High Frequency of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes.Childhood diabetes in the Nordic countries: a comparison of quality registries Feasibility of screening for T1D and celiac disease in a pediatric clinic setting Factors Associated with the Presence and Severity of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Korean Children and Adolescents.Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.Predictors of progression to Type 1 diabetes: preparing for immune interventions in the preclinical disease phase.Residual C-peptide in type 1 diabetes: what do we really know?How can cerebral edema during treatment of diabetic ketoacidosis be avoided?Building and Validating a Prediction model for Pediatric Type 1 Diabetes Risk Using Next Generation Targeted Sequencing of Class II HLA Genes.Beta-cell specific autoantibodies: Are they just an indicator of type 1 diabetes?Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes.Dysregulation of glucose metabolism in preclinical type 1 diabetes.A Swedish approach to the prevention of type 1 diabetes.Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels.Reduced frequency and severity of ketoacidosis at diagnosis of childhood type 1 diabetes in Northwest Saudi Arabia.Ketoacidosis at diagnosis of type 1 diabetes: Effect of prospective studies with newborn genetic screening and follow up of risk children.Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial.Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease.Reclassification of asymptomatic beta cell autoimmunity: a critical perspective.Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.Family adjustment to diabetes diagnosis in children: Can participation in a study on type 1 diabetes genetic risk be helpful?Residual beta-cell function in diabetes children followed and diagnosed in the TEDDY study compared to community controls.Screening for T1D risk to reduce DKA is not economically viable.Understanding Pre-Type 1 Diabetes: The Key to Prevention.Recruiting young pre-symptomatic children for a clinical trial in type 1 diabetes: Insights from the Fr1da insulin intervention study Phases of type 1 diabetes in children and adolescents

P2860

Q28282846-C9E088E1-100A-4934-8D31-AAC8FDD83BBB Q28602447-42E5BE9C-0464-4B2A-BE5D-3991DBF9B750 Q30235021-782DC93A-6294-4240-94FD-DC9D54DDB747 Q30407805-85C8E194-6B1C-4406-8E18-138A7DA50519 Q33819520-BA1BF7C0-B5B9-45B2-948F-8FB5271FF287 Q34308095-81CC4C3D-BE18-4D57-99C6-EBB7E18D6FCE Q36181376-763BC4E3-0D46-4A2A-AF7D-C2DF133093A3 Q36192718-9FBB32BC-0C90-47A2-A369-60C8DD09C847 Q36405223-AB4EFB10-9673-44ED-A5F4-38267698549C Q36608974-F817D184-A0FA-4E72-8646-06F7280B1CEE Q37164039-0233767C-0C7B-484F-8048-13122C41DC14 Q37570215-293016BD-4429-4E6B-8A18-14CFBBF6120B Q37659402-A6EC1557-9521-4B94-9020-242EDDAC87F5 Q38161556-1117898E-8A4F-48B5-ABD8-4B951ADE4DB9 Q38197230-5815293E-A13A-43B1-BF9C-EFF7FC74D63C Q38215324-69EC87FE-A46C-4586-9629-A0A5CDF708E2 Q38650009-D7851615-AD86-48A9-B368-76CCCAB9BF10 Q38818303-A8B3F51A-C390-440C-88D3-8CF6E807566E Q38828063-2DF10120-8D61-43B6-B0BB-804921B0180A Q38895409-9AE75F7C-E5F1-4425-AE3E-B38469CBAA55 Q38895430-716212AC-7587-40E4-94DF-186C0F5D29E4 Q39471328-F16E905B-D966-49AD-85C9-35CE9122B947 Q40324740-89EA7C33-2B53-45DF-B11E-D5AD2F5D76C4 Q47364345-71FAFCF9-38C9-43D0-B2C3-5C80E79A7BD5 Q47368833-5C0CE8B4-DF37-4A69-A37D-3A614A631226 Q47594106-8CF9A82D-BB06-49AA-847C-E22462CCA4EF Q48954491-CC80CAB5-ECF3-460A-B3D2-D15F30D7413B Q49110588-4BF01B7C-F0A7-49BB-95E1-577ABB04F592 Q52381998-E14ABD19-D75D-4276-8E8D-5D6649020D73 Q52798088-3B285071-3F7F-4138-9CCA-4EB3A0B5221B Q53342893-C57F3815-8CD3-43A2-AD97-B23B7C6E5CE8 Q55016896-F364AAB2-E155-4C99-8E81-0735DC46C1D7 Q57169199-088A6755-0F6F-4BAE-A4B9-91B92F91E133 Q57449039-7CA08064-D287-4D70-B1A0-B5D69C128343

P2860

Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up.

http://www.wikidata.org/entity/Q35408379

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Reduced prevalence of diabetic ...... ing in longitudinal follow-up.

@ast

Reduced prevalence of diabetic ...... ing in longitudinal follow-up.

@en

type

label

Reduced prevalence of diabetic ...... ing in longitudinal follow-up.

@ast

Reduced prevalence of diabetic ...... ing in longitudinal follow-up.

@en

prefLabel

Reduced prevalence of diabetic ...... ing in longitudinal follow-up.

@ast

Reduced prevalence of diabetic ...... ing in longitudinal follow-up.

@en

P1433

Q35408379-546E87B6-1C1F-4658-BF86-3239D92C293A

P1476

Q35408379-B87FDD5E-B35A-4100-9BC8-E61DE577C9DF

P2093

Q35408379-09B5A8B3-E928-41B9-8BF7-CE5BF505BB56

Q35408379-520463D8-D759-44E2-B4C2-91E0D9DE866A

Q35408379-61574D9D-D0BE-43C6-A994-273774F8B08B

Q35408379-A610A9EA-7554-4B51-A4C2-A21BCA3A8BA6

Q35408379-AE77651A-2B20-4492-B1BB-C2E66A9AFAEC

Q35408379-AEB514E5-1DE9-4448-9E7A-2B70D9B2B533

Q35408379-B4C04EA6-B6BE-4FA9-AB03-6884D24B517A

Q35408379-B9CB5478-1255-4694-9E8D-88FB8400578B

Q35408379-C4DCF03E-A933-4220-87A8-4758ADE7A63A

Q35408379-D7EFAEDB-BE5C-48CB-95C5-BD1BC3E7832C

P2860

Q35408379-09196628-0089-4028-95D9-29F4F45F5093

Q35408379-12563390-8909-4E57-A994-1C478AB07AA8

Q35408379-27EDDAAC-3CA2-4735-B476-2AB18BEFE3F0

Q35408379-30A8AB11-7EFF-43CE-A632-E0747DC980B9

Q35408379-341AD3A6-0D7F-41F8-86D5-44453BE83A0A

Q35408379-35F0FEE5-DB27-4CBA-A137-873604ACEF94

Q35408379-5C6767C6-6448-4F4D-8EFB-AB68C8EF9E7E

Q35408379-7752C94D-2E10-469F-8B5E-577FC37A7397

Q35408379-8A259708-A147-475B-AE02-EE1B1D1D0FF5

Q35408379-965E1ED7-1077-4FF2-8FFF-E3B9E6113EA6

P304

Q35408379-79DA92DC-86F8-4ABE-B89F-D34AF7523341

P31

Q35408379-093E17BC-4919-4748-88FF-FDC54572D951

P356

Q35408379-E664416B-538D-4813-8DFF-FAFB77C310A9

P407

Q35408379-BBB0AECC-142F-4440-ACD7-48F99C0AD81A

P433

Q35408379-63309163-18FB-4EA9-87C0-DE2A9681A0E8

P478

Q35408379-53B18118-EC38-4A12-A49E-9CB9916E6774

P50

Q35408379-49296B64-CE41-4226-AC5F-F69365467479

Q35408379-721D185E-9D15-4E34-9FFA-82A16322794F

Q35408379-7425BB0B-A045-48B5-8C29-5F9386834498

Q35408379-83EFCAFE-DA35-4529-ABB4-09BDFC5DBE9A

Q35408379-CD6CF464-7CF6-44DC-82A4-4CC7BF786236

Q35408379-CEEF3B64-5045-49A5-8689-540E2A098FA7

P577

Q35408379-FD7A7C78-84F5-4466-A507-554BD7010E2F

P5875

Q35408379-E577600E-D615-47B9-8DBB-9060AF1F3642

P698

Q35408379-A7B20A27-BF86-4E80-9956-2787D38A1ED0

P921

Q35408379-6F81694E-E87F-4CCB-B132-8B4F05DFF146

Q35408379-F9582173-1B29-4F74-912C-24E25118A135

P932

Q35408379-EEE19B37-584A-4732-8A97-13CF16C9B1B9

P356

P1433

P1476

Reduced prevalence of diabetic ...... ing in longitudinal follow-up.

@en

P2093

Bengt Lindblad

http://www.w3.org/2001/XMLSchema#string

Catherine Pihoker

http://www.w3.org/2001/XMLSchema#string

DPV Study Group

http://www.w3.org/2001/XMLSchema#string

Finnish Diabetes Registry Study Group

http://www.w3.org/2001/XMLSchema#string

Lawrence Dolan

http://www.w3.org/2001/XMLSchema#string

Michael J Haller

http://www.w3.org/2001/XMLSchema#string

Reinhard Holl

http://www.w3.org/2001/XMLSchema#string

Ronny Bell

http://www.w3.org/2001/XMLSchema#string

SEARCH Study Group

http://www.w3.org/2001/XMLSchema#string

Swediabkids Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

The rise of childhood type 1 diabetes in the 20th century.

Cerebral edema in diabetic ketoacidosis.

The Environmental Determinants of Diabetes in the Young (TEDDY) Study.

Age-related differences in the frequency of ketoacidosis at diagnosis of type 1 diabetes in children and adolescents.

Executive summary: standards of medical care in diabetes--2011.

Diabetic ketoacidosis at diagnosis in Austrian children in 1989-2008: a population-based analysis.

Identifying risk factors for the development of diabetic ketoacidosis in new onset type 1 diabetes mellitus.

Infant and toddler diabetes.

Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.

Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicenter analysis of 14,664 patients from 106 institutions.

P304

2347-2352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC11-1026

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Helena Elding Larsson

TEDDY Study Group

P577

2011-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51692536

http://www.w3.org/2001/XMLSchema#string

P698

21972409

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3198296

http://www.w3.org/2001/XMLSchema#string